Skip to main content

Table 2 Association between sarcopenia components and RAGE in gender difference using linear regression analysis

From: Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study

Gender

Variables

RAGE

Crude β coefficients

(95% CI)

P Value

Adjusted β coefficients

(95% CI)

P Value

All

Low muscle mass

162.80 (36.44, 289.16)

0.012

164.04 (36.02, 292.06)

0.012

Low muscle strength

181.31 (28.90, 333.71)

0.020

216.71 (50.88, 382.54)

0.011

Low gait speed

− 157.24 (−324.85, 10.38)

0.066

− 155.84 (− 331.54, 20.37)

0.083

Male

Low muscle mass

69.51 (− 112.77, 251.78)

0.452

27.51 (− 159.62, 214.64)

0.772

Low muscle strength

61.68 (− 183.08, 306.44)

0.619

−38.42 (− 323.85, 247.02)

0.790

Low gait speed

− 165.77 (− 392.22, 60.68)

0.150

− 264.37 (− 501.42, − 27.32)

0.029

Female

Low muscle mass

221.72 (45.51, 397.93)

0.014

239.47 (65.45, 413.48)

0.007

Low muscle strength

208.68 (7.04, 410.31)

0.043

303.28 (99.41, 507.14)

0.004

Low gait speed

− 142.96 (− 388.08, 102.16)

0.251

−71.93 (− 325.17, 181.32)

0.576

  1. aAdjusted covariates: age, sex, smoking, comorbidities (hypertension, diabetes mellitus, myocardial infarction, angina, coronary artery disease, and chronic obstructive pulmonary disease)